Rahma Warsame

6.8k citations
164 papers · 1.5k indexed · h-index 20
  • Hematology top 2%
    • Multiple Myeloma Research and Treatments 77
    • Chronic Myeloid Leukemia Treatments 17
  • Genetics top 5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 17
  • Oncology top 5%
    • CAR-T cell therapy research 17
    • Peptidase Inhibition and Analysis 16
  • Nephrology top 5%
    • Amyloidosis: Diagnosis, Treatment, Outcomes 43
    • Protein Degradation and Inhibitors 28
    • Health Systems, Economic Evaluations, Quality of Life 15

Rahma Warsame

146 papers receiving 1.5k citations

Peers

Rahma Warsame
Comparison fields: 5 of 94
  • Hematology 598
  • Genetics 287
  • Oncology 558
  • Nephrology 126
  • Molecular Biology 892
Replace Surbhi Sidana with:
Surbhi Sidana United States
Michael R. Grunwald United States
Rajshekhar Chakraborty United States
Binod Dhakal United States
James Cavet United Kingdom
Bernward Zeller Norway
Niti Goel United States
Olga Graciela Cantú‐Rodríguez Mexico
Shelly Carter United States
Anna Forsythe United States
Rahma Warsame relative to Surbhi Sidana United States Surbhi Sidana's profile →
Citations per field
00.5×1.5×2.2×
Surbhi Sidana · 1×
Citations per year

Countries citing papers authored by Rahma Warsame

Since Specialization
Citations

This map shows the geographic impact of Rahma Warsame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahma Warsame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahma Warsame more than expected).

Fields of papers citing papers by Rahma Warsame

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahma Warsame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahma Warsame. The network helps show where Rahma Warsame may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rahma Warsame, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rahma Warsame Line = papers co-authored together Rahma Warsame links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20241
4 20231
5 202313
6 20222
7 20226
8 20214
9 20216
10 20212
11 202032
12 202012
13 20202
14 201912
15 201914
16 201913
17 201931
18 201911
19 20197
20 201812

About Rahma Warsame

Rahma Warsame is a scholar working on Hematology, Genetics and Oncology, having authored 164 papers that have together received 1.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (77 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (43 papers), Protein Degradation and Inhibitors (28 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers), CAR-T cell therapy research (17 papers), Chronic Myeloid Leukemia Treatments (17 papers), Peptidase Inhibition and Analysis (16 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). The work is most often cited by research in Hematology (598 citations), Genetics (287 citations) and Oncology (558 citations). Rahma Warsame has collaborated with scholars based in United States, Saudi Arabia and Canada. Frequent co-authors include Angela Dispenzieri, Morie A. Gertz, Shaji Kumar, Prashant Kapoor, Martha Q. Lacy, David Dingli, Francis K. Buadi, Taxiarchis Kourelis, Wilson I. Gonsalves and Nelson Leung. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026